H R 6833 (2022)
Cap insulin copays at $35 per month
Summary:
Cap what diabetic patients with commercial health insurance pay for insulin at $35 per month.
Want hearing dates, vote records or the full bill text? See more on the Statehouse website
https://www.govtrack.us/congress/bills/117/hr6833
Browse related articles and bills: